Showing results (111-120 of 368) with videos related to
Sort By:
Pageof 37
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 13, 2022
Cancer Groundshot: Building a Robust Cancer Control Platform in Addition To Launching the Cancer MoonshotMiriam Mutebi, Navdeep Dehar, Leticia M Nogueira, et al.BMC Psychiatry|September 10, 2016
Prevalence and correlates of psychological distress symptoms among patients with substance use disorders in drug rehabilitation centers in urban Nepal: a cross-sectional studyBishal Gyawali, Bishnu P Choulagai, Damaru Prasad Paneru, et al.Ecancermedicalscience|March 5, 2024
The differential needs and expectations from general practitioners in oncology between high-income countries and low- and-middle-income countries: results from a survey of Canadian and Nepali oncologistsBishal Gyawali, Bishesh Sharma Poudyal, Laura M Carson, et al.Critical Reviews in Oncology/Hematology|February 21, 2018
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenarioAlfredo Addeo, Fabrizio Tabbò, Tim Robinson, et al.Frontiers in Oncology|May 7, 2019
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-AnalysisAlfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, et al.Therapeutic Advances in Drug Safety|April 15, 2021
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative reviewLaure Thouvenin, Timothée Olivier, Giuseppe Banna, et al.Frontiers in Medicine|June 13, 2022
First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond ChemoimmunotherapyEmilio Francesco Giunta, Alfredo Addeo, Alessio Rizzo, et al.Cancer Epidemiology|July 29, 2022
Trends in incidence and mortality of lung cancer in Switzerland: Possible explanations and open questionsDaniele Frisone, Jose Sandoval, Alex Friedlaender, et al.Current Oncology Reports|August 30, 2023
Cellular Therapy in NSCLC: Between Myth and RealityMartina Imbimbo, Laureline Wetterwald, Alex Friedlaender, et al.Critical Reviews in Oncology/Hematology|June 3, 2020
A BRAF new worldDaniele Frisone, Alex Friedlaender, Umberto Malapelle, et al.Pageof 37